Evidence map›Paper›PMID 38123455›Full record

ArticleThe Journal of infectious diseases2024

Detecting Residual Chronic Salmonella Typhi Carriers on the Road to Typhoid Elimination in Santiago, Chile, 2017-2019.

Rosanna M Lagos, Michael J Sikorski, Juan Carlos Hormazábal, Alda Fernandez, Sergio Duarte, Marcela F Pasetti, David A Rasko, Ellen Higginson, Joseph Nkeze, Irene N Kasumba and 5 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of infectious diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 3 countries.

Rosanna M LagosCentro para Vacunas en Desarollo-Chile, Hospital de Niños Roberto del Río, Santiago, Chile.
Michael J SikorskiCenter for Vaccine Development and Global Health.ORCID 0000-0002-3811-7285
Juan Carlos HormazábalSección Bacteriología, Subdepartamento de Enfermedades Infecciosas, Departamento de Laboratorio Biomédico, Instituto de Salud Pública de Chile, Santiago.
Alda FernandezSección Bacteriología, Subdepartamento de Enfermedades Infecciosas, Departamento de Laboratorio Biomédico, Instituto de Salud Pública de Chile, Santiago.
Sergio DuarteSección Bacteriología, Subdepartamento de Enfermedades Infecciosas, Departamento de Laboratorio Biomédico, Instituto de Salud Pública de Chile, Santiago.
Marcela F PasettiCenter for Vaccine Development and Global Health.
David A RaskoInstitute for Genome Sciences, Center for Pathogen Research, Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore.
Ellen HigginsonCenter for Vaccine Development and Global Health.
Joseph NkezeCenter for Vaccine Development and Global Health.
Irene N KasumbaCenter for Vaccine Development and Global Health.
Gordon DouganCambridge Institute for Therapeutic Immunology and Infectious Disease, University of Cambridge, United Kingdom.
Mailis MaesCambridge Institute for Therapeutic Immunology and Infectious Disease, University of Cambridge, United Kingdom.
Andrew LeesFina Biosolutions LLC, Rockville, Maryland.
Sharon M TennantCenter for Vaccine Development and Global Health.
Myron M LevineCenter for Vaccine Development and Global Health.ORCID 0000-0002-5721-5040
Center for Global Development · USInstituto de Salud Pública de Chile · CLUniversity of Cambridge · GBUniversity of Maryland, Baltimore · USEmergent BioSolutions (United States) · US

Funding

Technology CoreU19AI110820 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI CARNEIRO DA SILVA, JOANA · 2014 to 2023
$36.5M
Probiotic yeast secreting single-domain antibodies to prevent Clostridium difficile and Campylobacter jejuni diseaseU19AI142725 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI SZTEIN, MARCELO B. · 2019 to 2023
$12.5M
Research Training in Gastroenterology and HepatologyT32DK067872 · NIDDK · UNIVERSITY OF MARYLAND BALTIMORE · PI RAUFMAN, JEAN-PIERRE · 2005 to 2024
$7.2M
Genomics of Salmonella Typhi in Samoa: Population structure and genomic epidemiologyF30AI156973 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI SIKORSKI, MICHAEL JOSEPH · 2021 to 2024
$158k
NIAID NIH HHS F30 AI156973NIAID NIH HHS U19 AI110820NIDDK NIH HHS T32 DK067872Wellcome Sanger InstituteWellcome Trust
6 · The paper itself

Abstract

backgroundIn Santiago, Chile, where typhoid had been hyperendemic (1977-1991), we investigated whether residual chronic carriers could be detected among household contacts of non-travel-related typhoid cases occurring during 2017-2019.

methodsCulture-confirmed cases were classified as autochthonous (domestically acquired) versus travel/immigration related. Household contacts of cases had stool cultures and serum Vi antibody measurements to detect chronic Salmonella Typhi carriers. Whole genome sequences of acute cases and their epidemiologically linked chronic carrier isolates were compared.

resultsFive of 16 autochthonous typhoid cases (31.3%) were linked to 4 chronic carriers in case households; 2 cases (onsets 23 months apart) were linked to the same carrier. Carriers were women aged 69-79 years with gallbladder dysfunction and Typhi fecal excretion; 3 had highly elevated serum anti-Vi titers. Genomic analyses revealed close identity (≤11 core genome single-nucleotide polymorphism [SNP] differences) between case and epidemiologically linked carrier isolates; all were genotypes prevalent in 1980s Santiago. A cluster of 4 additional autochthonous cases unlinked to a carrier was identified based on genomic identity (0-1 SNPs). Travel/immigration isolate genotypes were typical for the countries of travel/immigration.

conclusionsAlthough autochthonous typhoid cases in Santiago are currently rare, 5 of 16 such cases (31.3%) were linked to elderly chronic carriers identified among household contacts of cases.

Indexed as

Carrier StateSalmonella typhiTyphoid FeverAdolescentAdultAgedAged, 80 and overChildChild, PreschoolChileFecesFemaleGenotypeHumansMaleMiddle Agedchronic typhoid carriersshort-cycle typhoid transmissiontransmission of typhoidtyphoid eliminationtyphoid fever

Identifiers

PMID38123455
PMCPMC11326835
OpenAlexW4390023568

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.